Colonization of C57BL/6 mice by a potential probiotic Bifidobacterium bifidum strain under germ-free and specific pathogen-free conditions and during experimental colitis

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Grimm, Verena ^a   Radulovic, Katarina ^a,b   Riedel, Christian U ^a  

^a UNIVERSITY OF ULM   (Germany)

^b INSERM U1019   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIABILITY; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; C57BL 6 MOUSE; CACO 2 CELL LINE; COLONY FORMING UNIT; CONTROLLED STUDY; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; FEMALE; GASTROINTESTINAL TRACT; HUMAN; HUMAN CELL; INTESTINE; INTESTINE EPITHELIUM CELL; MICROFLORA; MOUSE; NONHUMAN; ORGANISMAL INTERACTION; POPULATION STRUCTURE; ANIMAL; BIFIDOBACTERIUM; C57BL MOUSE; CACO-2 CELL LINE; CHEMICALLY INDUCED; COLITIS; GERMFREE ANIMAL; MICROBIOLOGY;

DEXTRAN SULFATE; PROBIOTIC AGENT;

ANIMALS; BIFIDOBACTERIUM; CACO-2 CELLS; COLITIS; DEXTRAN SULFATE; HUMANS; INTESTINES; MICE; MICE, INBRED C57BL; MICROBIOTA; PROBIOTICS; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 84947999013     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139935     Document Type: Article

References (58)

1. Bottacini F, Ventura M, van Sinderen D, O'Connell Motherway M (2014) Diversity, ecology and intestinal function of bifidobacteria. Microb Cell Fact 13 Suppl 1: S4. doi: 10.1186/1475-2859-13-S1-S4 PMID: 25186128
2. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, et al. (2000) Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 30: 61-67. PMID: 10630441
3. Kurokawa K, Itoh T, Kuwahara T, Oshima K, Toh H, et al. (2007) Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res An Int J Rapid Publ Reports Genes Genomes 14: 169-181. doi: 10.1093/dnares/dsm018
4. Turroni F, Peano C, Pass DA, Foroni E, Severgnini M, et al. (2012) Diversity of Bifidobacteria within the Infant Gut Microbiota. PLoS One 7: e36957. doi: 10.1371/journal.pone.0036957 PMID: 22606315
5. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, et al. (2012) Human gut microbiome viewed across age and geography. Nature 486: 222-227. doi: 10.1038/nature11053 PMID: 22699611
6. Riedel CU, Schwiertz A, Egert M (2014) The Stomach and Small and Large Intestinal Microbiomes. In: Marchesi JR, editor. The Human Microbiota and Microbiome. CABI.
7. Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, et al. (2013) The long-term stability of the human gut microbiota. Science 341: 1237439. doi: 10.1126/science.1237439 PMID: 23828941
8. Human Microbiome Project Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature 486: 207-214. doi: 10.1038/nature11234 PMID: 22699609
9. Lawley TD, Walker AW (2013) Intestinal colonization resistance. Immunology 138: 1-11. doi: 10.1111/j.1365-2567.2012.03616.x PMID: 23240815
10. Sekirov I, Russell SL, Antunes LCM, Finlay BB (2010) Gut microbiota in health and disease. Physiol Rev 90: 859-904. doi: 10.1152/physrev.00045.2009 PMID: 20664075
11. Gareau MG, Sherman PM, Walker WA (2010) Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol 7: 503-514. doi: 10.1038/nrgastro.2010.117 PMID: 20664519
12. Sommer F, Bäckhed F (2013) The gut microbiota - masters of host development and physiology. Nat Rev Microbiol 11: 227-238. doi: 10.1038/nrmicro2974 PMID: 23435359
13. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, et al. (2011) Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469: 543-547. doi: 10.1038/nature09646 PMID: 21270894
14. Fanning S, Hall LJ, Cronin M, Zomer A, Macsharry J, et al. (2012) Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci U S A 109: 2108-2113. doi: 10.1073/pnas.1115621109 PMID: 22308390
15. Asahara T, Shimizu K, Nomoto K, Hamabata T, Ozawa A, et al. (2004) Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. Infect Immun 72: 2240-2247. PMID: 15039348
16. Cho JH (2008) The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 8: 458-466. doi: 10.1038/nri2340 PMID: 18500230
17. Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434. PMID: 17653185
18. Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, et al. (2005) Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 206: 260-276. doi: 10.1111/j.0105-2896.2005.00291.x PMID: 16048554
19. Wirtz S, Neufert C, Weigmann B, Neurath MF (2007) Chemically induced mouse models of intestinal inflammation. Nat Protoc 2: 541-546. PMID: 17406617
20. Geier MS, Butler RN, Giffard PM, Howarth GS (2007) Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats. Int J Food Microbiol 114: 267-274. PMID: 17150273
21. Gkouskou KK, Deligianni C, Tsatsanis C, Eliopoulos AG (2014) The gut microbiota in mouse models of inflammatory bowel disease. Front Cell Infect Microbiol 4: 28. doi: 10.3389/fcimb.2014.00028 PMID: 24616886
22. Heuvelin E, Lebreton C, Grangette C, Pot B, Cerf-Bensussan N, et al. (2009) Mechanisms Involved in Alleviation of Intestinal Inflammation by Bifidobacterium breve Soluble Factors. PLoS One 4: e5184. doi: 10.1371/journal.pone.0005184 PMID: 19381276
23. Kwon H-K, Lee C-G, So J-S, Chae C-S, Hwang J-S, et al. (2010) Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A 107: 2159-2164. doi: 10.1073/pnas.0904055107 PMID: 20080669
24. Veiga P, Gallini CA, Beal C, Michaud M, Delaney ML, et al. (2010) Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc Natl Acad Sci U S A 107: 18132-18137. doi: 10.1073/pnas.1011737107 PMID: 20921388
25. Jeon SG, Kayama H, Ueda Y, Takahashi T, Asahara T, et al. (2012) Probiotic Bifidobacterium breve Induces IL-10-Producing Tr1 Cells in the Colon. PLoS Pathog 8: e1002714Jeon. doi: 10.1371/journal.ppat.1002714 PMID: 22693446
26. Zhurina D, Zomer A, Gleinser M, Brancaccio VF, Auchter M, et al. (2011) Complete genome sequence of Bifidobacterium bifidum S17. J Bacteriol 193: 301-302. doi: 10.1128/JB.01180-10 PMID: 21037011
27. Riedel CU, Foata F, Goldstein DR, Blum S, Eikmanns BJ (2006) Interaction of bifidobacteria with Caco-2 cells-adhesion and impact on expression profiles. Int J Food Microbiol 110: 62-68. PMID: 16713644
28. Preising J, Philippe D, Gleinser M, Wei H, Blum S, et al. (2010) Selection of bifidobacteria based on adhesion and anti-inflammatory capacity in vitro for amelioration of murine colitis. Appl Environ Microbiol 76: 3048-3051. doi: 10.1128/AEM.03127-09 PMID: 20228095
29. Riedel CU, Foata F, Philippe D, Adolfsson O, Eikmanns BJ, et al. (2006) Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kappaB activation. World J Gastroenterol WJG 12: 3729-3735. PMID: 16773690
30. Philippe D, Heupel E, Blum-Sperisen S, Riedel CU (2011) Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis. Int J Food Microbiol 149: 45-49. doi: 10.1016/j.ijfoodmicro.2010.12.020 PMID: 21257218
31. Ventura M, Turroni F, Motherway MO, Macsharry J, van Sinderen D (2012) Host-microbe interactions that facilitate gut colonization by commensal bifidobacteria. Trends Microbiol 20: 467-476. doi: 10.1016/j.tim.2012.07.002 PMID: 22902802
32. Turroni F, Serafini F, Foroni E, Duranti S, O'Connell Motherway M, et al. (2013) Role of sortase-dependent pili of Bifidobacterium bifidum PRL2010 in modulating bacterium-host interactions. Proc Natl Acad Sci U S A 110: 11151-11156. doi: 10.1073/pnas.1303897110 PMID: 23776216
33. O'Connell Motherway M, Zomer A, Leahy SC, Reunanen J, Bottacini F, et al. (2011) Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor. Proc Natl Acad Sci U S A 108: 11217-11222. doi: 10.1073/pnas.1105380108 PMID: 21690406
34. Guglielmetti S, Tamagnini I, Mora D, Minuzzo M, Scarafoni A, et al. (2008) Implication of an outer surface lipoprotein in adhesion of Bifidobacterium bifidum to Caco-2 cells. Appl Environ Microbiol 74: 4695-4702. doi: 10.1128/AEM.00124-08 PMID: 18539800
35. Gleinser M, Grimm V, Zhurina D, Yuan J, Riedel CU (2012) Improved adhesive properties of recombinant bifidobacteria expressing the Bifidobacterium bifidum-specific lipoprotein BopA. Microb Cell Fact 11: 80. doi: 10.1186/1475-2859-11-80 PMID: 22694891
36. Grimm V, Gleinser M, Neu C, Zhurina D, Riedel CU (2014) Expression of fluorescent proteins in bifidobacteria for analysis of host-microbe interactions. Appl Environ Microbiol 80: 2842-2850. doi: 10.1128/AEM.04261-13 PMID: 24584243
37. Frank JA, Reich CI, Sharma S, Weisbaum JS, Wilson BA, et al. (2008) Critical evaluation of two primers commonly used for amplification of bacterial 16S rRNA genes. Appl Environ Microbiol 74: 2461-2470. doi: 10.1128/AEM.02272-07 PMID: 18296538
38. Kim O-S, Cho Y-J, Lee K, Yoon S-H, Kim M, et al. (2012) Introducing EzTaxon-e: a prokaryotic 16S rRNA gene sequence database with phylotypes that represent uncultured species. Int J Syst Evol Microbiol 62: 716-721. doi: 10.1099/ijs.0.038075-0 PMID: 22140171
39. Manta C, Heupel E, Radulovic K, Rossini V, Garbi N, et al. (2013) CX(3)CR1(+) macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium. Mucosal Immunol 6: 177-188. doi: 10.1038/mi.2012.61 PMID: 22854708
40. Singh N, Arioli S, Wang A, Villa CR, Jahani R, et al. (2013) Impact of Bifidobacterium bifidum MIMBb75 on mouse intestinal microorganisms. FEMS Microbiol Ecol 85: 369-375. doi: 10.1111/1574-6941.12124 PMID: 23551062
41. Schwarz R, Kaspar A, Seelig J, Künnecke B (2002) Gastrointestinal transit times in mice and humans measured with 27Al and 19F nuclear magnetic resonance. Magn Reson Med Off J Soc Magn Reson Med/Soc Magn Reson Med 48: 255-261.
42. Turroni F, Taverniti V, Ruas-Madiedo P, Duranti S, Guglielmetti S, et al. (2014) Bifidobacterium bifidum PRL2010 Modulates the Host Innate Immune Response. Appl Environ Microbiol 80: 730-740. doi: 10.1128/AEM.03313-13 PMID: 24242237
43. Duranti S, Turroni F, Lugli GA, Milani C, Viappiani A, et al. (2014) Genomic characterization and transcriptional studies of the starch-utilizing Bifidobacterium adolescentis 22L. Appl Environ Microbiol 80: 6080-6090. doi: 10.1128/AEM.01993-14 PMID: 25063659
44. Liu T, Matsuguchi T, Tsuboi N, Yajima T, Yoshikai Y (2002) Differences in expression of toll-like receptors and their reactivities in dendritic cells in BALB/c and C57BL/6 mice. Infect Immun 70: 6638-6645. PMID: 12438336
45. Stewart D, Fulton WB, Wilson C, Monitto CL, Paidas CN, et al. (2002) Genetic contribution to the septic response in a mouse model. Shock 18: 342-347. PMID: 12392278
46. Hsieh CS, Macatonia SE, O'Garra A, Murphy KM (1995) T cell genetic background determines default T helper phenotype development in vitro. J Exp Med 181: 713-721. PMID: 7836924
47. Mariman R, Tielen F, Koning F, Nagelkerken L (2015) The Probiotic Mixture VSL#3 Has Differential Effects on Intestinal Immune Parameters in Healthy Female BALB/c and C57BL/6 Mice. J Nutr 145: 1354-1361. doi: 10.3945/jn.114.199729 PMID: 25948785
48. Norin KE, Persson AK, Saxerholt H, Midtvedt T (1991) Establishment of Lactobacillus and Bifidobacterium species in germfree mice and their influence on some microflora-associated characteristics. Appl Environ Microbiol 57: 1850-1852. PMID: 1872614
49. Ménard O, Butel M-J, Gaboriau-Routhiau V, Waligora-Dupriet A-J (2008) Gnotobiotic mouse immune response induced by Bifidobacterium sp. strains isolated from infants. Appl Environ Microbiol 74: 660-666. doi: 10.1128/AEM.01261-07 PMID: 18083875
50. Marcobal A, Barboza M, Sonnenburg ED, Pudlo N, Martens EC, et al. (2011) Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell Host Microbe 10: 507-514. doi: 10.1016/j.chom.2011.10.007 PMID: 22036470
51. Sela DA, Mills DA (2010) Nursing our microbiota: molecular linkages between bifidobacteria and milk oligosaccharides. Trends Microbiol 18: 298-307. doi: 10.1016/j.tim.2010.03.008 PMID: 20409714
52. Pan X, Yang Y, Zhang J-R (2014) Molecular basis of host specificity in human pathogenic bacteria. Emerg Microbes Infect 3: e23. doi: 10.1038/emi.2014.23 PMID: 26038515
53. Westermann C, Zhurina DS, Baur A, Shang W, Yuan J, et al. (2012) Exploring the genome sequence of Bifidobacterium bifidum S17 for potential players in host-microbe interactions. Symbiosis 58: 191-200. doi: 10.1007/s13199-012-0205-z
54. Grimm V, Westermann C, Riedel CU (2014) Bifidobacteria-Host Interactions-An Update on Colonisation Factors. Biomed Res Int 2014: 960826. doi: 10.1155/2014/960826 PMID: 25295282
55. Prisciandaro L, Geier M, Butler R, Cummins A, Howarth G (2009) Probiotics and their derivatives as treatments for inflammatory bowel disease. Inflamm Bowel Dis 15: 1906-1914. doi: 10.1002/ibd.20938 PMID: 19373788
56. Adams CA (2010) The probiotic paradox: live and dead cells are biological response modifiers. Nutr Res Rev 23: 37-46. doi: 10.1017/S0954422410000090 PMID: 20403231
57. Lahtinen SJ (2012) Probiotic viability - does it matter? Microb Ecol Health Dis 23. doi: 10.3402/mehd.v23i0.18567
58. Ewaschuk JB, Diaz H, Meddings L, Diederichs B, Dmytrash A, et al. (2008) Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol 295: G1025-G1034. doi: 10.1152/ajpgi.90227.2008 PMID: 18787064